11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction.
about
11β-Hydroxysteroid Dehydrogenase 2 in PreeclampsiaDevelopmental perturbation induced by maternal asthma during pregnancy: the short- and long-term impacts on offspringProstaglandins and leukotriene B4 are potent inhibitors of 11beta-hydroxysteroid dehydrogenase type 2 activity in human choriocarcinoma JEG-3 cellsReciprocal changes in maternal and fetal metabolism of corticosterone in rat during gestationPlacental Origins of Chronic Disease.Modulation of the Hypothalamic-Pituitary-Adrenal Axis by Early Life Stress ExposurePrenatal stress induces increased striatal dopamine transporter binding in adult nonhuman primatesPrenatal programing: at the intersection of maternal stress and immune activationAssociation between umbilical cord glucocorticoids and blood pressure at age 3 years.Diurnal rhythm of cortisol during late pregnancy: associations with maternal psychological well-being and fetal growth.Site-specific methylation of placental HSD11B2 gene promoter is related to intrauterine growth restriction.Induction of 11β-HSD 1 and activation of distinct mineralocorticoid receptor- and glucocorticoid receptor-dependent gene networks in decidualizing human endometrial stromal cells.Timing of fetal exposure to stress hormones: effects on newborn physical and neuromuscular maturationElevation of 11β-hydroxysteroid dehydrogenase type 2 activity in Holocaust survivor offspring: evidence for an intergenerational effect of maternal trauma exposureChildren of addicted womenLack of renal 11 beta-hydroxysteroid dehydrogenase type 2 at birth, a targeted temporal window for neonatal glucocorticoid action in human and mice.Placental 11-beta hydroxysteroid dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioral outcome.Caffeine reduces 11β-hydroxysteroid dehydrogenase type 2 expression in human trophoblast cells through the adenosine A(2B) receptor.Epigenetic effects of prenatal stress on 11β-hydroxysteroid dehydrogenase-2 in the placenta and fetal brainProgramming of adrenocortical function and the fetal origins of adult disease.Early onset pre-eclampsia is associated with altered DNA methylation of cortisol-signalling and steroidogenic genes in the placentaTiming of prenatal maternal exposure to severe life events and adverse pregnancy outcomes: a population study of 2.6 million pregnancies.Placental adaptations in growth restriction.Programming of the hypothalamo-pituitary-adrenal axis: serotonergic involvement.Glucocorticoid Metabolism in Hypertensive Disorders of Pregnancy: Analysis of Plasma and Urinary Cortisol and Cortisone.Biomarkers of hypothalamic-pituitary-adrenal axis activity in mice lacking 11β-HSD1 and H6PDHMaternal Prenatal Mental Health and Placental 11β-HSD2 Gene Expression: Initial Findings from the Mercy Pregnancy and Emotional Wellbeing Study.Glucocorticoid "programming" and PTSD risk.Intrauterine growth restriction: fetal programming of hypertension and kidney disease.Early prenatal food supplementation ameliorates the negative association of maternal stress with birth size in a randomised trialCauses of intrauterine growth restriction and the postnatal development of the metabolic syndrome.Expression of eight glucocorticoid receptor isoforms in the human preterm placenta vary with fetal sex and birthweight.Repeated betamethasone treatment of pregnant sheep programs persistent reductions in circulating IGF-I and IGF-binding proteins in progeny.Prospective evaluation of associations between prenatal cortisol and adulthood coronary heart disease risk: the New England family study.Potential significance of physiological and pharmacological glucocorticoids in early pregnancy.A role for glucocorticoids in stress-impaired reproduction: beyond the hypothalamus and pituitary.Elevated maternal cortisol levels during pregnancy are associated with reduced childhood IQ11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.Early restriction of placental growth results in placental structural and gene expression changes in late gestation independent of fetal hypoxemia.The link between perinatal glucocorticoids exposure and psychiatric disorders.
P2860
Q26747322-CEAC3883-DE1C-4CB6-B79D-0CA44CB6FDBAQ26822770-BABBB380-7E1F-4E61-BB6F-C1052BB759F2Q28378047-A3F23918-935A-4B7B-BA0E-61131ED6D786Q28575896-13E0E561-ECBE-45EE-8388-3F1B99E6BDE8Q30245567-948848C2-262C-4C0A-A5D9-CDF7B07C738CQ30357256-81BF6BDF-F875-4BB9-B41C-62295A154F32Q30429526-C37814E3-F3BD-4B6A-BA49-7D862210138AQ30451449-54E57F52-F593-4B54-AA59-2C9A2371F533Q33364551-CDC7707A-E859-4437-8693-6DB3788FB4FFQ33588950-578A8E69-EDF9-47D4-8582-2BAEFD228E8FQ33620784-91B56885-1065-417B-A211-C6C323E0B0E3Q33637083-EB3443CB-7A28-4B94-A722-723F7F4A6471Q33778595-41347743-72B9-47BE-A507-EF616020E204Q34022913-E20987E5-568F-458E-9DE3-1F1CE6C4897DQ34111219-02CD3C10-54AD-4174-9E1F-50476E939DB9Q34168478-705C5923-88C0-4F32-AF9D-36C1370AD7A1Q34203026-42D7375E-C343-47A1-9AE4-32BC0BF76969Q34305291-4B3E4618-F71C-4B19-B55B-A8178D540FA0Q34326531-CE271E40-7A59-49C0-91E9-EAD8C503F229Q34444346-5E092F2D-582E-4B2D-9391-B43B606AA19CQ34717931-F2CC10EA-DD07-4774-9CCF-19310F7224E4Q34761863-58BEBC79-68C5-4FD1-9F57-40BE9E68DB01Q35003807-1EA2BE0A-DB1E-4726-9091-9264EB0A89B9Q35809328-3C2AFB01-B685-48E5-B26C-B06C09CEA7F2Q35861229-8093BE4C-B295-4EA8-80D3-6FEFABFBD354Q36189049-1855E0AE-851E-48CA-82BC-9A54D91A3536Q36324720-4DC68B13-A1B4-4057-A20E-3BAF60F49D9AQ36557730-683C9168-875C-4C14-B9B2-148C0569C946Q36569856-06472C6B-5059-4F73-815F-BE0456989A58Q36693925-AF7D2D21-72F1-40D0-BB99-63B20632E131Q36739188-17982524-81CA-4919-8331-58F2A980D545Q36794567-4D8B4AA7-182B-4024-9229-DF1835E07056Q36805453-A766D298-1A28-4F24-890C-78CFC0607413Q37137330-D0B6E396-F0C7-4717-92B9-DD2D9135972FQ37190719-0F24A274-E73A-420B-B085-62FEFB594D24Q37331052-A80D607E-9BB0-4056-8E83-B4F021B49966Q37450367-3744FD5A-1564-4A2C-A44B-7ACAA3F653F0Q37655884-921C36CB-CE81-435E-ACF2-EEF8E13A00D5Q37710682-5698BD9F-7600-4F95-ADA2-051F878D78AAQ37834928-9D117512-5E0D-42F6-80EA-F1375CA36691
P2860
11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
11Beta-hydroxysteroid dehydrog ...... trauterine growth restriction.
@en
11Beta-hydroxysteroid dehydrog ...... trauterine growth restriction.
@nl
type
label
11Beta-hydroxysteroid dehydrog ...... trauterine growth restriction.
@en
11Beta-hydroxysteroid dehydrog ...... trauterine growth restriction.
@nl
prefLabel
11Beta-hydroxysteroid dehydrog ...... trauterine growth restriction.
@en
11Beta-hydroxysteroid dehydrog ...... trauterine growth restriction.
@nl
P2093
P356
P1433
P1476
11Beta-hydroxysteroid dehydrog ...... trauterine growth restriction.
@en
P2093
Somerset DA
Stewart PM
P304
P356
10.1093/HUMREP/13.4.799
P407
P577
1998-04-01T00:00:00Z